Rezolute is a clinical stage biopharmaceutical company specializing in the development of innovative drug therapies to improve the lives of patients with metabolic and orphan diseases.

Biotechnology

Rezolute

Rezolute's headquarters in Redwood City, CA, United States

Nevan Charles Elam

Michael R. Deperro

Sunil Karnawat

Daron Evans

Melissa Q.

Susan Stewart, JD, LL.M

Jeffrey Breit, Ph.D.

Brian Roberts

Gil Labrucherie

Alvin Schmaier

Adrian Vella

Robert B. Bhisitkul

Vlad Hogenhuis

Philippe Fauchet

Young-Jin Kim

Jerrold Olefsky

Nerissa Kreher

Quan Dong Nguyen

The Research and Development team at Rezolute is dedicated to advancing innovative drug therapies for metabolic and orphan diseases. Comprising experts in drug discovery, clinical operations, and scientific research, the team collaborates on designing and implementing clinical trials, optimizing pharmaceutical sciences, and translating scientific insights into viable treatment options to enhance patient outcomes.

Research and Development

The Leadership Team at Rezolute plays a pivotal role in steering the company's strategic direction and decision-making processes. Comprising experts in clinical development, finance, technical operations, quality assurance, and specialized areas such as ophthalmological research, this team collaborates to drive innovative drug therapies from concept to clinical fruition, ensuring regulatory compliance and the highest standards of patient safety and efficacy. Their collective expertise ensures that Rezolute is poised tomake significant advancements in treating metabolic and orphan diseases.

Leadership Team

The Regulatory Affairs team at Rezolute is responsible for ensuring compliance with regulatory requirements for the development and approval of innovative drug therapies. They navigate the complex landscape of regulatory submissions, engage with health authorities, and provide strategic guidance on new product development, all aimed at advancing Rezolute's mission to improve patient outcomes in metabolic and orphan diseases.

Regulatory Affairs

The Product Supply and Quality Assurance team at Rezolute is responsible for ensuring a seamless supply chain and maintaining the highest quality standards for the company's innovative drug therapies. This team coordinates global supply planning, oversees quality sciences, and leads drug product management, all while ensuring compliance with regulatory requirements to support the successful development and delivery of treatments for metabolic and orphan diseases.

Product Supply and Quality Assurance

The Clinical Operations team at Rezolute is responsible for overseeing the planning, execution, and management of clinical trials for innovative drug therapies. They ensure compliance with regulatory requirements, optimize operational efficiency, and coordinate with cross-functional teams to advance clinical development programs, ultimately aiming to improve patient outcomes in metabolic and orphan diseases.

Clinical Operations

The Finance and Accounting team at Rezolute is responsible for managing the company's financial health and ensuring compliance with regulatory standards. This team oversees budgeting, financial reporting, and accounting operations, providing critical insights to support strategic decision-making in the development of innovative therapies. Their efforts help secure funding and allocate resources effectively to advance Rezolute's mission in the biopharmaceutical industry.

Rezolute

Org chart

Board & advisors

Teams

Research and Development

Leadership Team

Regulatory Affairs

Product Supply and Quality Assurance

Clinical Operations

Finance and Accounting

Offices

Rezolute

Org chart

Board & advisors

Teams

Research and Development

Leadership Team

Regulatory Affairs

Product Supply and Quality Assurance

Clinical Operations

Finance and Accounting

Offices

Related companies